(Total Views: 117)
Posted On: 06/08/2022 8:21:06 AM
Post# of 74551

$ALDX News Article - Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 TRANQUILITY?2 Trial in Dry Eye Disease and Intends to Submit New Drug Application for Symptoms and Three Sign Endpoints of Dry Eye Disease https://marketwirenews.com/news-releases/alde...36511.html


My Twitter: WhyteStocks